Experiment 508622
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | GORDON,M: GURALNIK,M: KANEKO,Y: MIMURA,T: BAKER,M: LANG,W:. (1994). A PHASE I STUDY OF CURDLAN SULFATE-AN HIV INHIBITOR. TOLERANCE, PHARMACOKINETICS AND EFFECTS ON COAGULATION AND ON CD4 LYMPHOCYTES.. 25(3/4) |
| Amount utilized | |
| Compound isolated | |
| Disease | DOSE INFUSED OVER 4 HOURS. IN HIV-INFECTED PERSONS. |
| Dose amount | 3.0 MG |
| Number | 3 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | KG |
| Dose expression | DOSE |